Live register
Drugs in short supply
1,174 products are currently reported in shortage to the FDA. Each row links to the manufacturer’s entry, so you can see what else they make and where.
By therapeutic category
Anesthesia306
Pediatric245
Psychiatry190
Gastroenterology132
Analgesia/Addiction123
Endocrinology/Metabolism106
Neurology97
Other97
| Drug | Manufacturer | Presentation | Availability | Updated |
|---|---|---|---|---|
| Atropine Sulfate Injection | Amphastar Pharmaceuticals, Inc. | Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1) | Available | 18 Aug 26 |
| Carboplatin Injection | Teyro Labs | Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6) | Unavailable | 18 Aug 26 |
| Carboplatin Injection | Teyro Labs | Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7) | Unavailable | 18 Aug 26 |
| Carboplatin Injection | Teyro Labs | Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1) | Unavailable | 18 Aug 26 |
| Carboplatin Injection | Teyro Labs | Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3) | Unavailable | 18 Aug 26 |
| Dextrose Monohydrate 50% Injection | Amphastar Pharmaceuticals, Inc. | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1) | Available | 18 Aug 26 |
| Lidocaine Hydrochloride Injection | Amphastar Pharmaceuticals, Inc. | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1) | Limited Availability | 18 Aug 26 |
| Lorazepam Injection | Amphastar Pharmaceuticals, Inc. | Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1) | Available | 18 Aug 26 |
| Morphine Sulfate Injection | Amphastar Pharmaceuticals, Inc. | Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1) | Available | 18 Aug 26 |
| Sodium Bicarbonate Injection | Amphastar Pharmaceuticals, Inc. | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1) | Limited Availability | 18 Aug 26 |
| Amino Acid Injection | Baxter Healthcare | Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-04) | Available | 17 Aug 26 |
| Amino Acid Injection | Baxter Healthcare | PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, Injection, 2.76 g/100 mL; 1.96 g/100 mL; 600 mg/100 mL; 1.02 g/100 mL; 2.06 g/100 mL; 1.18 g/100 mL; 1.08 g/100 mL; 1.08 g/100 mL; 1.35 g/100 mL; 760 mg/100 mL; 1 g/100 mL; 1.34 g/100 mL; 1.02 g/100 mL; 980 mg/100 mL; 320 mg/100 mL; 50 mg/100 mL; 1.44 g/100 mL (NDC 0338-0499-06) | Available | 17 Aug 26 |
| Amino Acid Injection | Baxter Healthcare | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-03) | Unavailable | 17 Aug 26 |
| Amino Acid Injection | Baxter Healthcare | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-04) | Available | 17 Aug 26 |
| Amino Acid Injection | Otsuka ICU Medical LLC | Aminosyn II 10% In Plastic Container, Injection, 0.1 (NDC 0990-7172-17) | Available | 17 Aug 26 |
| Amino Acid Injection | Baxter Healthcare | Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-06) | Available | 17 Aug 26 |
| Amino Acid Injection | Otsuka ICU Medical LLC | Aminosyn II 15% In Plastic Container, Injection, 0.15 (NDC 0990-7171-17) | Available | 17 Aug 26 |
| Amino Acid Injection | Baxter Healthcare | Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-06) | Available | 17 Aug 26 |
| Amino Acid Injection | Baxter Healthcare | Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-03) | Available | 17 Aug 26 |
| Amino Acid Injection | Otsuka ICU Medical LLC | Aminosyn-PF 10%, Injection, 0.1 (NDC 0990-4179-05) | Unavailable | 17 Aug 26 |
| Amino Acid Injection | Baxter Healthcare | Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-03) | Available | 17 Aug 26 |
| Amino Acid Injection | Otsuka ICU Medical LLC | Aminosyn-PF 7%, Injection, 0.07 (NDC 0990-4178-03) | Unavailable | 17 Aug 26 |
| Amino Acid Injection | Baxter Healthcare | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-06) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0555-0775-02) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 64850-503-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 64850-500-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 57844-115-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 64850-506-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 15mg (NDC 47781-178-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 64850-502-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 64850-501-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5mg (NDC 47781-174-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0555-0776-02) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 10mg (NDC 47781-176-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 20mg (NDC 47781-179-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0555-0777-02) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 64850-504-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 57844-105-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 57844-130-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 64850-505-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 30mg (NDC 47781-180-01) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0555-0972-02) | Available | 17 Aug 26 |
| Atropine Sulfate Injection | American Regent, Inc. | Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25) | Available | 17 Aug 26 |
| Atropine Sulfate Injection | Accord Healthcare Inc. | Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90) | Unavailable | 17 Aug 26 |
| Atropine Sulfate Injection | Accord Healthcare Inc. | Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03) | Unavailable | 17 Aug 26 |
| Atropine Sulfate Injection | American Regent, Inc. | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25) | Available | 17 Aug 26 |
| Atropine Sulfate Injection | Accord Healthcare Inc. | Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08) | Unavailable | 17 Aug 26 |
| Atropine Sulfate Injection | Accord Healthcare Inc. | Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45) | Available | 17 Aug 26 |
| Atropine Sulfate Injection | Medefil, Inc. | Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91) | Available | 17 Aug 26 |
| Azacitidine Injection | Accord Healthcare Inc. | Azacitidine, Injection, 100 mg (NDC 16729-306-10) | Available | 17 Aug 26 |
| Azacitidine Injection | Teva Pharmaceuticals USA, Inc. | Azacitidine, Injection, 100 mg (NDC 68001-313-56) | Unavailable | 17 Aug 26 |
| Carboplatin Injection | Accord Healthcare Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34) | Unavailable | 17 Aug 26 |
| Carboplatin Injection | Accord Healthcare Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31) | Unavailable | 17 Aug 26 |
| Carboplatin Injection | Accord Healthcare Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12) | Unavailable | 17 Aug 26 |
| Carboplatin Injection | Accord Healthcare Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33) | Unavailable | 17 Aug 26 |
| Clindamycin Phosphate Injection | Baxter Healthcare | Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50) | Available | 17 Aug 26 |
| Clindamycin Phosphate Injection | Baxter Healthcare | Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50) | Limited Availability | 17 Aug 26 |
| Clindamycin Phosphate Injection | Baxter Healthcare | Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50) | Available | 17 Aug 26 |
| Clindamycin Phosphate Injection | Baxter Healthcare | Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50) | Available | 17 Aug 26 |
| Clonazepam Tablet | Cheplapharm Arzneimittel GmbH | Klonopin, Tablet, 2 mg (NDC 61269-620-10) | Available | 17 Aug 26 |
| Clonazepam Tablet | Accord Healthcare Inc. | Clonazepam, Tablet, 1 mg (NDC 16729-137-16) | Available | 17 Aug 26 |
| Clonazepam Tablet | Accord Healthcare Inc. | Clonazepam, Tablet, 2 mg (NDC 16729-138-00) | Available | 17 Aug 26 |
| Clonazepam Tablet | Accord Healthcare Inc. | Clonazepam, Tablet, 2 mg (NDC 16729-138-16) | Available | 17 Aug 26 |
| Clonazepam Tablet | Accord Healthcare Inc. | Clonazepam, Tablet, .5 mg (NDC 16729-136-16) | Available | 17 Aug 26 |
| Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Clonazepam, Tablet, .5 mg (NDC 0093-0832-01) | Available | 17 Aug 26 |
| Clonazepam Tablet | Accord Healthcare Inc. | Clonazepam, Tablet, .5 mg (NDC 16729-136-00) | Available | 17 Aug 26 |
| Clonazepam Tablet | Cheplapharm Arzneimittel GmbH | Klonopin, Tablet, .5 mg (NDC 61269-605-10) | Available | 17 Aug 26 |
| Clonazepam Tablet | Cheplapharm Arzneimittel GmbH | Klonopin, Tablet, 1 mg (NDC 61269-610-10) | Available | 17 Aug 26 |
| Clonazepam Tablet | Accord Healthcare Inc. | Clonazepam, Tablet, 1 mg (NDC 16729-137-00) | Available | 17 Aug 26 |
| Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Clonazepam, Tablet, 2 mg (NDC 0093-3213-01) | Available | 17 Aug 26 |
| Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Clonazepam, Tablet, 2 mg (NDC 0093-3213-05) | Available | 17 Aug 26 |
| Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Clonazepam, Tablet, 1 mg (NDC 0093-3212-05) | Available | 17 Aug 26 |
| Cromolyn Sodium Concentrate | Micro Labs LTD | Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 42571-132-52) | Available | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Azurity Pharmaceuticals, Inc | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 72572-127-10) | Available | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24) | Available | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12) | Available | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | HQ Specialty Pharma | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04) | Available | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Accord Healthcare Inc. | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93) | Unavailable | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Accord Healthcare Inc. | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93) | Unavailable | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12) | Available | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Azurity Pharmaceuticals, Inc | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08) | Available | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | HQ Specialty Pharma | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04) | Available | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | HQ Specialty Pharma | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24) | Available | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | HQ Specialty Pharma | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24) | Available | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Azurity Pharmaceuticals, Inc | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10) | Available | 17 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Azurity Pharmaceuticals, Inc | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 72572-128-08) | Available | 17 Aug 26 |
| Dextrose Monohydrate 10% Injection | Otsuka ICU Medical LLC | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-02) | Available | 17 Aug 26 |
| Dextrose Monohydrate 10% Injection | Baxter Healthcare | Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04) | Available | 17 Aug 26 |
| Dextrose Monohydrate 10% Injection | Otsuka ICU Medical LLC | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7938-19) | Unavailable | 17 Aug 26 |
| Dextrose Monohydrate 10% Injection | Otsuka ICU Medical LLC | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03) | Available | 17 Aug 26 |
| Dextrose Monohydrate 10% Injection | Otsuka ICU Medical LLC | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-09) | Available | 17 Aug 26 |
| Dextrose Monohydrate 10% Injection | Baxter Healthcare | Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02) | Available | 17 Aug 26 |
| Dextrose Monohydrate 10% Injection | Baxter Healthcare | Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-61) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-55) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-38) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-18) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0070-10) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-9666-35) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-02) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 2.5 g/50 mL (NDC 0338-9664-40) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-09) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-20) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0074-30) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-48) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-37) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0078-20) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-36) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-18) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-03) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-11) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-02) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-31) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-03) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-10) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-11) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-23) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-41) | Available | 17 Aug 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-13) | Available | 17 Aug 26 |
| Dextrose Monohydrate 70% Injection | Otsuka ICU Medical LLC | DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7918-19) | Available | 17 Aug 26 |
| Dextrose Monohydrate 70% Injection | Otsuka ICU Medical LLC | DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07) | Available | 17 Aug 26 |
| Dextrose Monohydrate 70% Injection | Baxter Healthcare | Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0338-0719-06) | Unavailable | 17 Aug 26 |
| Dobutamine Hydrochloride Injection | Baxter Healthcare | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02) | Available | 17 Aug 26 |
| Dobutamine Hydrochloride Injection | Baxter Healthcare | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02) | Available | 17 Aug 26 |
| Dobutamine Hydrochloride Injection | Baxter Healthcare | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02) | Available | 17 Aug 26 |
| Dopamine Hydrochloride Injection | Baxter Healthcare | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03) | Available | 17 Aug 26 |
| Dopamine Hydrochloride Injection | Baxter Healthcare | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03) | Available | 17 Aug 26 |
| Dopamine Hydrochloride Injection | Baxter Healthcare | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02) | Available | 17 Aug 26 |
| Dopamine Hydrochloride Injection | Baxter Healthcare | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02) | Available | 17 Aug 26 |
| Furosemide Injection | Accord Healthcare Inc. | Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43) | Unavailable | 17 Aug 26 |
| Furosemide Injection | Accord Healthcare Inc. | Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08) | Unavailable | 17 Aug 26 |
| Furosemide Injection | Accord Healthcare Inc. | Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43) | Unavailable | 17 Aug 26 |
| Furosemide Injection | Baxter Healthcare | Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25) | Available | 17 Aug 26 |
| Furosemide Injection | Baxter Healthcare | Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25) | Available | 17 Aug 26 |
| Furosemide Injection | Baxter Healthcare | Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25) | Available | 17 Aug 26 |
| Heparin Sodium Injection | Baxter Healthcare | Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04) | Available | 17 Aug 26 |
| Heparin Sodium Injection | Baxter Healthcare | Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03) | Available | 17 Aug 26 |
| Hydromorphone Hydrochloride Injection | Teva Pharmaceuticals USA, Inc. | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03) | Available | 17 Aug 26 |
| Hydromorphone Hydrochloride Injection | Teva Pharmaceuticals USA, Inc. | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03) | Available | 17 Aug 26 |
| Hydromorphone Hydrochloride Injection | Teva Pharmaceuticals USA, Inc. | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01) | Available | 17 Aug 26 |
| Hydroxocobalamin Injection | BTG International Inc. | Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11) | Limited Availability | 17 Aug 26 |
| Ifosfamide Injection | Baxter Healthcare | IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01) | Unavailable | 17 Aug 26 |
| Ifosfamide Injection | Baxter Healthcare | IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01) | Unavailable | 17 Aug 26 |
| Ifosfamide Injection | Baxter Healthcare | Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02) | Unavailable | 17 Aug 26 |
| Ifosfamide Injection | Baxter Healthcare | Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01) | Unavailable | 17 Aug 26 |
| Ketorolac Tromethamine Injection | Baxter Healthcare | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) | Unavailable | 17 Aug 26 |
| Lidocaine Hydrochloride Injection | Baxter Healthcare | Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02) | Available | 17 Aug 26 |
| Lidocaine Hydrochloride Injection | Baxter Healthcare | Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03) | Available | 17 Aug 26 |
| Liraglutide Injection | Novo Nordisk, Inc. | Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) | Available | 17 Aug 26 |
| Liraglutide Injection | Novo Nordisk, Inc. | Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12) | Limited Availability | 17 Aug 26 |
| Liraglutide Injection | Novo Nordisk, Inc. | Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13) | Limited Availability | 17 Aug 26 |
| Liraglutide Injection | Novo Nordisk, Inc. | Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20) | Available | 17 Aug 26 |
| Liraglutide Injection | Novo Nordisk, Inc. | Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01) | Limited Availability | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01) | Limited Availability | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01) | Limited Availability | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01) | Limited Availability | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01) | Limited Availability | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01) | Limited Availability | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01) | Available | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01) | Limited Availability | 17 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01) | Available | 17 Aug 26 |
| Methotrexate Sodium Injection | Accord Healthcare Inc. | Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-35) | Available | 17 Aug 26 |
| Methotrexate Sodium Injection | Accord Healthcare Inc. | Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-30) | Available | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10) | Available | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30) | Available | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10) | Limited Availability | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30) | Available | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30) | Limited Availability | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30) | Available | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10) | Available | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30) | Available | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10) | Limited Availability | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30) | Limited Availability | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30) | Available | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10) | Limited Availability | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Teva Pharmaceuticals USA, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01) | Available | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10) | Limited Availability | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10) | Available | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30) | Available | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30) | Limited Availability | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10) | Available | 17 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30) | Available | 17 Aug 26 |
| Metronidazole Injection | Baxter Healthcare | Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48) | Available | 17 Aug 26 |
| Midazolam Hydrochloride Injection | WG Critical Care | Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10) | Available | 17 Aug 26 |
| Midazolam Hydrochloride Injection | WG Critical Care | Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10) | Available | 17 Aug 26 |
| Peginterferon alfa-2a Injection | pharmaand GmbH (pharma&) | Pegasys, Injection, 180 ug/.5 mL (NDC 82154-0451-4) | Available | 17 Aug 26 |
| Peginterferon alfa-2a Injection | pharmaand GmbH (pharma&) | Pegasys, Injection, 180 ug/1 mL (NDC 82154-0449-1) | Unavailable | 17 Aug 26 |
| Penicillin G Benzathine Injection | Laboratorios Atral | Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01) | Available | 17 Aug 26 |
| Riluzole Oral Suspension | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1) | Available | 17 Aug 26 |
| Riluzole Oral Suspension | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1) | Available | 17 Aug 26 |
| Riluzole Oral Suspension | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1) | Unavailable | 17 Aug 26 |
| Riluzole Oral Suspension | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1) | Available | 17 Aug 26 |
| Rocuronium Bromide Injection | Baxter Healthcare | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) | Available | 17 Aug 26 |
| Rocuronium Bromide Injection | XGen Pharmaceuticals DJB, Inc. | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) | Available | 17 Aug 26 |
| Rocuronium Bromide Injection | Baxter Healthcare | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) | Available | 17 Aug 26 |
| Rocuronium Bromide Injection | XGen Pharmaceuticals DJB, Inc. | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) | Available | 17 Aug 26 |
| Sodium Bicarbonate Injection | Long Grove Pharmaceuticals LLC | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3) | Available | 17 Aug 26 |
| Sterile Water Injection | Medefil, Inc. | Sterile Water, Injection, 10 mL/10 mL (NDC 64253-020-30) | Available | 17 Aug 26 |
| Sterile Water Irrigant | Baxter Healthcare | Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-04) | Limited Availability | 17 Aug 26 |
| Sterile Water Irrigant | Baxter Healthcare | Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-03) | Limited Availability | 17 Aug 26 |
| Sterile Water Irrigant | Otsuka ICU Medical LLC | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-09) | Unavailable | 17 Aug 26 |
| Sterile Water Irrigant | Otsuka ICU Medical LLC | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-03) | Unavailable | 17 Aug 26 |
| Sterile Water Irrigant | Otsuka ICU Medical LLC | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-36) | Unavailable | 17 Aug 26 |
| Sterile Water Irrigant | Otsuka ICU Medical LLC | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-22) | Unavailable | 17 Aug 26 |
| Sterile Water Irrigant | Baxter Healthcare | Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-02) | Available | 17 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 11534-192-01) | Available | 16 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 11534-190-01) | Available | 16 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 11534-194-01) | Available | 16 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 11534-193-01) | Available | 16 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 11534-195-01) | Available | 16 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 11534-191-01) | Available | 16 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 11534-196-01) | Available | 16 Aug 26 |
| Azacitidine Injection | Bristol Myers Squibb Co. | Vidaza, Injection, 100 mg (NDC 59572-102-01) | Available | 16 Aug 26 |
| Methylphenidate Film, Extended Release | Noven Pharmaceuticals, Inc. | Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65) | Available | 15 Aug 26 |
| Methylphenidate Film, Extended Release | Noven Pharmaceuticals, Inc. | Methylphenidate, Film, Extended Release, 10 mg (NDC 0574-2410-65) | Available | 15 Aug 26 |
| Methylphenidate Film, Extended Release | Noven Pharmaceuticals, Inc. | Methylphenidate, Film, Extended Release, 30 mg (NDC 0574-2430-65) | Available | 15 Aug 26 |
| Methylphenidate Film, Extended Release | Noven Pharmaceuticals, Inc. | Methylphenidate, Film, Extended Release, 15 mg (NDC 0574-2415-65) | Available | 15 Aug 26 |
| Sodium Acetate Injection | Milla Pharmaceuticals | Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10) | Limited Availability | 15 Aug 26 |
| Sodium Acetate Injection | Milla Pharmaceuticals | Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10) | Available | 15 Aug 26 |
| Sodium Acetate Injection | Milla Pharmaceuticals | Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10) | Available | 15 Aug 26 |
| Sodium Acetate Injection | Milla Pharmaceuticals | Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10) | Available | 15 Aug 26 |
| Atropine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10) | Available | 13 Aug 26 |
| Azacitidine Injection | Hikma Pharmaceuticals USA, Inc. | Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01) | Available | 13 Aug 26 |
| Bumetanide Injection | Hikma Pharmaceuticals USA, Inc. | Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6008-10) | Available | 13 Aug 26 |
| Cefotaxime Sodium Powder, for Solution | Hikma Pharmaceuticals USA, Inc. | Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10) | Unavailable | 13 Aug 26 |
| Cefotaxime Sodium Powder, for Solution | Hikma Pharmaceuticals USA, Inc. | Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25) | Unavailable | 13 Aug 26 |
| Cefotaxime Sodium Powder, for Solution | Hikma Pharmaceuticals USA, Inc. | Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01) | Unavailable | 13 Aug 26 |
| Cefotaxime Sodium Powder, for Solution | Hikma Pharmaceuticals USA, Inc. | Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25) | Unavailable | 13 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Hikma Pharmaceuticals USA, Inc. | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25) | Available | 13 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Hikma Pharmaceuticals USA, Inc. | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25) | Available | 13 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Hikma Pharmaceuticals USA, Inc. | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25) | Available | 13 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25) | Unavailable | 13 Aug 26 |
| Dopamine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25) | Unavailable | 13 Aug 26 |
| Dopamine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25) | Unavailable | 13 Aug 26 |
| Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10) | Available | 13 Aug 26 |
| Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) | Available | 13 Aug 26 |
| Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10) | Available | 13 Aug 26 |
| Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) | Available | 13 Aug 26 |
| Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10) | Available | 13 Aug 26 |
| Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10) | Available | 13 Aug 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05) | Unavailable | 13 Aug 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25) | Available | 13 Aug 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25) | Available | 13 Aug 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25) | Unavailable | 13 Aug 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10) | Unavailable | 13 Aug 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01) | Unavailable | 13 Aug 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25) | Available | 13 Aug 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10) | Unavailable | 13 Aug 26 |
| Furosemide Oral Solution | Hikma Pharmaceuticals USA, Inc. | Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-50) | Limited Availability | 13 Aug 26 |
| Furosemide Oral Solution | Hikma Pharmaceuticals USA, Inc. | Furosemide, Oral Solution, 40 mg/5 mL (NDC 0054-3298-63) | Limited Availability | 13 Aug 26 |
| Furosemide Oral Solution | Hikma Pharmaceuticals USA, Inc. | Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-46) | Limited Availability | 13 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01) | Unavailable | 13 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25) | Available | 13 Aug 26 |
| Ifosfamide Injection | Hikma Pharmaceuticals USA, Inc. | Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01) | Unavailable | 13 Aug 26 |
| Ifosfamide Injection | Hikma Pharmaceuticals USA, Inc. | Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01) | Unavailable | 13 Aug 26 |
| Ketorolac Tromethamine Injection | Hikma Pharmaceuticals USA, Inc. | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) | Unavailable | 13 Aug 26 |
| Ketorolac Tromethamine Injection | Hikma Pharmaceuticals USA, Inc. | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) | Unavailable | 13 Aug 26 |
| Ketorolac Tromethamine Injection | Hikma Pharmaceuticals USA, Inc. | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) | Unavailable | 13 Aug 26 |
| Lidocaine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10) | Available | 13 Aug 26 |
| Lidocaine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25) | Available | 13 Aug 26 |
| Lidocaine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10) | Available | 13 Aug 26 |
| Lidocaine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25) | Available | 13 Aug 26 |
| Liraglutide Injection | Hikma Pharmaceuticals USA, Inc. | Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03) | Available | 13 Aug 26 |
| Liraglutide Injection | Hikma Pharmaceuticals USA, Inc. | Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02) | Available | 13 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25) | Limited Availability | 13 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25) | Limited Availability | 13 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25) | Limited Availability | 13 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25) | Limited Availability | 13 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25) | Limited Availability | 13 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25) | Limited Availability | 13 Aug 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25) | Unavailable | 13 Aug 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10) | Unavailable | 13 Aug 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10) | Unavailable | 13 Aug 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25) | Limited Availability | 13 Aug 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10) | Unavailable | 13 Aug 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25) | Unavailable | 13 Aug 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25) | Limited Availability | 13 Aug 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10) | Unavailable | 13 Aug 26 |
| Meperidine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25) | Available | 13 Aug 26 |
| Meperidine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25) | Available | 13 Aug 26 |
| Meperidine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25) | Available | 13 Aug 26 |
| Methotrexate Sodium Injection | Hikma Pharmaceuticals USA, Inc. | Methotrexate, Preservative Free, Injection, 1 g (NDC 0143-9830-01) | Unavailable | 13 Aug 26 |
| Methotrexate Sodium Injection | Hikma Pharmaceuticals USA, Inc. | Methotrexate, Preservative Free, Injection, 25 mg/1 mL (NDC 0143-9519-10) | Available | 13 Aug 26 |
| Midazolam Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10) | Available | 13 Aug 26 |
| Midazolam Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01) | Unavailable | 13 Aug 26 |
| Midazolam Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25) | Available | 13 Aug 26 |
| Midazolam Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10) | Available | 13 Aug 26 |
| Midazolam Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25) | Available | 13 Aug 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01) | Available | 13 Aug 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25) | Available | 13 Aug 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25) | Available | 13 Aug 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10) | Available | 13 Aug 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25) | Available | 13 Aug 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01) | Available | 13 Aug 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10) | Available | 13 Aug 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25) | Available | 13 Aug 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25) | Available | 13 Aug 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25) | Unavailable | 13 Aug 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25) | Available | 13 Aug 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-1496-35) | Unavailable | 13 Aug 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25) | Unavailable | 13 Aug 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35) | Available | 13 Aug 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25) | Unavailable | 13 Aug 26 |
| Propranolol Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10) | Unavailable | 13 Aug 26 |
| Rocuronium Bromide Injection | Hikma Pharmaceuticals USA, Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) | Available | 13 Aug 26 |
| Rocuronium Bromide Injection | Hikma Pharmaceuticals USA, Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) | Available | 13 Aug 26 |
| Sodium Acetate Injection | Hikma Pharmaceuticals USA, Inc. | Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01) | Available | 13 Aug 26 |
| Sterile Water Injection | Hikma Pharmaceuticals USA, Inc. | Sterile Water, Injection, 1 mL/1 mL (NDC 0641-6147-10) | Available | 13 Aug 26 |
| Sufentanil Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02) | Unavailable | 13 Aug 26 |
| Sufentanil Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01) | Unavailable | 13 Aug 26 |
| Sufentanil Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05) | Unavailable | 13 Aug 26 |
| Valproate Sodium Injection | Hikma Pharmaceuticals USA, Inc. | Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10) | Available | 13 Aug 26 |
| Penicillin G Benzathine Injection | Pfizer Inc. | Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10) | Limited Availability | 12 Aug 26 |
| Penicillin G Benzathine Injection | Pfizer Inc. | Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10) | Limited Availability | 12 Aug 26 |
| Penicillin G Benzathine Injection | Pfizer Inc. | Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10) | Unavailable | 12 Aug 26 |
| Quinapril Hydrochloride Tablet | Lupin Pharmaceuticals, Inc. | Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09) | Unavailable | 12 Aug 26 |
| Quinapril Hydrochloride Tablet | Lupin Pharmaceuticals, Inc. | Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09) | Unavailable | 12 Aug 26 |
| Quinapril Hydrochloride Tablet | Lupin Pharmaceuticals, Inc. | Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09) | Unavailable | 12 Aug 26 |
| Quinapril Hydrochloride Tablet | Lupin Pharmaceuticals, Inc. | Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09) | Unavailable | 12 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sandoz Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0185-2098-01) | Available | 11 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sandoz Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01) | Available | 11 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sandoz Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0185-0853-01) | Available | 11 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sandoz Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0185-0842-01) | Available | 11 Aug 26 |
| Bumetanide Injection | Mullan Pharmaceutical Inc. | Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2) | Available | 11 Aug 26 |
| Bumetanide Injection | Mullan Pharmaceutical Inc. | Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2) | Available | 11 Aug 26 |
| Clindamycin Phosphate Injection | Sandoz Inc. | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09) | Available | 11 Aug 26 |
| Clindamycin Phosphate Injection | Sandoz Inc. | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09) | Available | 11 Aug 26 |
| Clindamycin Phosphate Injection | Sandoz Inc. | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24) | Available | 11 Aug 26 |
| Clindamycin Phosphate Injection | Sandoz Inc. | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09) | Available | 11 Aug 26 |
| Clindamycin Phosphate Injection | Sandoz Inc. | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24) | Available | 11 Aug 26 |
| Rocuronium Bromide Injection | Sandoz Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) | Available | 11 Aug 26 |
| Rocuronium Bromide Injection | Sandoz Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92) | Available | 11 Aug 26 |
| Technetium TC-99M Pyrophosphate Kit Injection | Curium US LLC | Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20) | Limited Availability | 11 Aug 26 |
| Cromolyn Sodium Concentrate | Mylan Specialty, a Viatris Company | Gastrocrom, Concentrate, 20 mg/1 mL (NDC 0037-0678-96) | Available | 10 Aug 26 |
| Echothiophate Iodide Ophthalmic Solution | Fera Pharmaceuticals | Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05) | Available | 10 Aug 26 |
| Amino Acid Injection | B. Braun Medical Inc. | Plenamine, Injection, 0.15 (NDC 0264-4500-05) | Available | 07 Aug 26 |
| Amino Acid Injection | B. Braun Medical Inc. | Plenamine, Injection, 0.15 (NDC 0264-4500-00) | Available | 07 Aug 26 |
| Amino Acid Injection | B. Braun Medical Inc. | TrophAmine 10%, Injection, 0.1 (NDC 0264-1933-10) | Available | 07 Aug 26 |
| Atropine Sulfate Injection | Hospira, Inc., a Pfizer Company | Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10) | Unavailable | 07 Aug 26 |
| Atropine Sulfate Injection | Hospira, Inc., a Pfizer Company | Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)" | Unavailable | 07 Aug 26 |
| Atropine Sulfate Injection | Hospira, Inc., a Pfizer Company | Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05) | Available | 07 Aug 26 |
| Atropine Sulfate Injection | Hospira, Inc., a Pfizer Company | Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)" | Unavailable | 07 Aug 26 |
| Bumetanide Injection | Hikma Pharmaceuticals USA, Inc. | Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6007-10) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 0.25%; 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-10) | Unavailable | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1559-10) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1559-30) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10) | Unavailable | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-2253-01) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01) | Limited Availability | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 150 mg/30 mL (5 mg/mL) (NDC 0409-1560-29) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 50 mg/10 mL (5 mg/mL) (NDC 0409-1560-10) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1165-01) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-10) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000) (NDC 0409-1755-50) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride and Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-9043-01) | Unavailable | 07 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC 0409-1752-50) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-9046-01) | Unavailable | 07 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-30) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride And Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-9042-17) | Unavailable | 07 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride And Epinephrine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-9042-01) | Unavailable | 07 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride And Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01) | Unavailable | 07 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000) (NDC 0409-1749-29) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000) (NDC 0409-1749-10) | Available | 07 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride and Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-9045-17) | Unavailable | 07 Aug 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05) | Unavailable | 07 Aug 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50) | Unavailable | 07 Aug 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18) | Unavailable | 07 Aug 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18) | Unavailable | 07 Aug 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05) | Unavailable | 07 Aug 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56) | Unavailable | 07 Aug 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05) | Unavailable | 07 Aug 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22) | Unavailable | 07 Aug 26 |
| Clindamycin Phosphate Injection | Baxter Healthcare | Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50) | Unavailable | 07 Aug 26 |
| Clindamycin Phosphate Injection | Pfizer Inc. | Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26) | Unavailable | 07 Aug 26 |
| Clindamycin Phosphate Injection | Pfizer Inc. | Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL) (NDC 0009-3051-02) | Unavailable | 07 Aug 26 |
| Clindamycin Phosphate Injection | Pfizer Inc. | Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL) (NDC 0009-5095-06) | Unavailable | 07 Aug 26 |
| Clindamycin Phosphate Injection | Baxter Healthcare | Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50) | Unavailable | 07 Aug 26 |
| Clindamycin Phosphate Injection | Pfizer Inc. | Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL) (NDC 0009-4073-04) | Unavailable | 07 Aug 26 |
| Clindamycin Phosphate Injection | Pfizer Inc. | Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26) | Available | 07 Aug 26 |
| Clindamycin Phosphate Injection | Pfizer Inc. | Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18) | Available | 07 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Mylan Institutional, a Viatris Company | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12) | Available | 07 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Mylan Institutional, a Viatris Company | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54) | Available | 07 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Mylan Institutional, a Viatris Company | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30) | Available | 07 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Mylan Institutional, a Viatris Company | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24) | Unavailable | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Mylan Institutional, a Viatris Company | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Mylan Institutional, a Viatris Company | Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Mylan Institutional, a Viatris Company | Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20) | Available | 07 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10) | Available | 07 Aug 26 |
| Dextrose Monohydrate 10% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-00) | Available | 07 Aug 26 |
| Dextrose Monohydrate 10% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20) | Available | 07 Aug 26 |
| Dextrose Monohydrate 10% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10) | Available | 07 Aug 26 |
| Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-31) | Available | 07 Aug 26 |
| Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-20) | Available | 07 Aug 26 |
| Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-00) | Available | 07 Aug 26 |
| Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-10) | Available | 07 Aug 26 |
| Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-32) | Available | 07 Aug 26 |
| Dextrose Monohydrate 50% Injection | Hospira, Inc., a Pfizer Company | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-4902-34) | Unavailable | 07 Aug 26 |
| Dextrose Monohydrate 50% Injection | Hospira, Inc., a Pfizer Company | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16) | Available | 07 Aug 26 |
| Dextrose Monohydrate 50% Injection | Hospira, Inc., a Pfizer Company | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02) | Limited Availability | 07 Aug 26 |
| Dextrose Monohydrate 70% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50) | Available | 07 Aug 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (400 mg/mL) (NDC 0409-3724-32) | Available | 07 Aug 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01) | Available | 07 Aug 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02) | Available | 07 Aug 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88) | Unavailable | 07 Aug 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (200 mg/mL) (NDC 0409-2347-32) | Available | 07 Aug 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (100 mg/mL) (NDC 0409-2346-32) | Available | 07 Aug 26 |
| Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20) | Available | 07 Aug 26 |
| Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-7809-22) | Available | 07 Aug 26 |
| Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01) | Available | 07 Aug 26 |
| Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-7810-22) | Available | 07 Aug 26 |
| Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24) | Unavailable | 07 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01) | Limited Availability | 07 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03) | Available | 07 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01) | Unavailable | 07 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02) | Limited Availability | 07 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01) | Available | 07 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 2.5 g/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01) | Unavailable | 07 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01) | Unavailable | 07 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02) | Unavailable | 07 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03) | Limited Availability | 07 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01) | Limited Availability | 07 Aug 26 |
| Etomidate Injection | Hospira, Inc., a Pfizer Company | Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) | Available | 07 Aug 26 |
| Etomidate Injection | Mylan Institutional, a Viatris Company | Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20) | Available | 07 Aug 26 |
| Etomidate Injection | Hospira, Inc., a Pfizer Company | Amidate, Injection, 2 mg/mL (NDC 0409-6695-02) | Unavailable | 07 Aug 26 |
| Etomidate Injection | Mylan Institutional, a Viatris Company | Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10) | Available | 07 Aug 26 |
| Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61) | Available | 07 Aug 26 |
| Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22) | Available | 07 Aug 26 |
| Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31) | Limited Availability | 07 Aug 26 |
| Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28) | Available | 07 Aug 26 |
| Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25) | Available | 07 Aug 26 |
| Furosemide Injection | Hospira, Inc., a Pfizer Company | Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02) | Available | 07 Aug 26 |
| Furosemide Injection | Hospira, Inc., a Pfizer Company | Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25) | Unavailable | 07 Aug 26 |
| Furosemide Injection | Hospira, Inc., a Pfizer Company | Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26) | Unavailable | 07 Aug 26 |
| Furosemide Injection | Hospira, Inc., a Pfizer Company | Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04) | Available | 07 Aug 26 |
| Furosemide Injection | Hospira, Inc., a Pfizer Company | Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-27) | Next Delivery and Estimated Recovery: December 2028 | 07 Aug 26 |
| Furosemide Injection | Hospira, Inc., a Pfizer Company | Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10) | Available | 07 Aug 26 |
| Heparin Sodium Injection | Hospira, Inc., a Pfizer Company | Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-7620-59) | Available | 07 Aug 26 |
| Heparin Sodium Injection | B. Braun Medical Inc. | Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00) | Available | 07 Aug 26 |
| Heparin Sodium Injection | B. Braun Medical Inc. | Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10) | Available | 07 Aug 26 |
| Heparin Sodium Injection | Hospira, Inc., a Pfizer Company | Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03) | Available | 07 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31) | Available | 07 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50) | Available | 07 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30) | Available | 07 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01) | Unavailable | 07 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36) | Available | 07 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37) | Unavailable | 07 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01) | Available | 07 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10) | Available | 07 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01) | Limited Availability | 07 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05) | Available | 07 Aug 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31) | Available | 07 Aug 26 |
| Ketorolac Tromethamine Injection | Hospira, Inc., a Pfizer Company | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) | Unavailable | 07 Aug 26 |
| Ketorolac Tromethamine Injection | Hospira, Inc., a Pfizer Company | Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) | Unavailable | 07 Aug 26 |
| Ketorolac Tromethamine Injection | Baxter Healthcare | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) | Unavailable | 07 Aug 26 |
| Ketorolac Tromethamine Injection | Hospira, Inc., a Pfizer Company | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01) | Unavailable | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | B. Braun Medical Inc. | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01) | Unavailable | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | B. Braun Medical Inc. | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | B. Braun Medical Inc. | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 100 mg/5mL (2%, 20 mg/1 mL) Syringes (NDC 0409-4903-34) | Unavailable | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 50 mg/5mL (1%,10 mg/1 mL) Syringes (NDC 0409-4904-34) | Unavailable | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01) | Available | 07 Aug 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05) | Limited Availability | 07 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77) | Available | 07 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77) | Available | 07 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77) | Available | 07 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77) | Available | 07 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77) | Available | 07 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77) | Available | 07 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77) | Available | 07 Aug 26 |
| Lorazepam Injection | Hospira, Inc., a Pfizer Company | Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30) | Limited Availability | 07 Aug 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30) | Unavailable | 07 Aug 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30) | Available | 07 Aug 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 50 mg/1 mL (NDC 0409-1418-01) | Unavailable | 07 Aug 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30) | Available | 07 Aug 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 25 mg/1 mL (NDC 0409-1362-01) | Unavailable | 07 Aug 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 75 mg/1 mL (NDC 0409-1179-30) | Unavailable | 07 Aug 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 100 mg/1 mL (NDC 0409-1180-69) | Unavailable | 07 Aug 26 |
| Methotrexate Sodium Injection | Hospira, Inc., a Pfizer Company | Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-25) | Available | 07 Aug 26 |
| Methotrexate Sodium Injection | Hospira, Inc., a Pfizer Company | Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-10) | Available | 07 Aug 26 |
| Methotrexate Sodium Injection | Hospira, Inc., a Pfizer Company | Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-41) | Available | 07 Aug 26 |
| Methotrexate Sodium Injection | Hospira, Inc., a Pfizer Company | Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-124-40) | Available | 07 Aug 26 |
| Methotrexate Sodium Injection | Hospira, Inc., a Pfizer Company | Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-38) | Available | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52) | Available | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12) | Available | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03) | Limited Availability | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51) | Available | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01) | Limited Availability | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02) | Available | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02) | Available | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03) | Available | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03) | Limited Availability | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01) | Available | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23) | Limited Availability | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22) | Unavailable | 07 Aug 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01) | Limited Availability | 07 Aug 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17) | Available | 07 Aug 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03) | Available | 07 Aug 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05) | Available | 07 Aug 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01) | Unavailable | 07 Aug 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05) | Limited Availability | 07 Aug 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02) | Available | 07 Aug 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05) | Available | 07 Aug 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12) | Available | 07 Aug 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01) | Available | 07 Aug 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12) | Available | 07 Aug 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 8 mg/1 mL Syringes (NDC 0409-1892-01) | Unavailable | 07 Aug 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20) | Unavailable | 07 Aug 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01) | Unavailable | 07 Aug 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01) | Available | 07 Aug 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1134-05) | Unavailable | 07 Aug 26 |
| Quinapril Hydrochloride Tablet | Pfizer Inc. | Accupril, Tablet, 10 mg (NDC 0071-0530-23) | Unavailable | 07 Aug 26 |
| Quinapril Hydrochloride Tablet | Pfizer Inc. | Accupril, Tablet, 5 mg (NDC 0071-0527-23) | Unavailable | 07 Aug 26 |
| Quinapril Hydrochloride Tablet | Pfizer Inc. | Accupril, Tablet, 20 mg (NDC 0071-0532-23) | Unavailable | 07 Aug 26 |
| Quinapril Hydrochloride Tablet | Pfizer Inc. | Accupril, Tablet, 40 mg (NDC 0071-0535-23) | Unavailable | 07 Aug 26 |
| Quinapril/Hydrochlorothiazide Tablet | Pfizer Inc. | Accuretic, Tablet, 25 mg/20 mg (NDC 0071-0223-23) | Unavailable | 07 Aug 26 |
| Quinapril/Hydrochlorothiazide Tablet | Pfizer Inc. | Accuretic, Tablet, 10 mg/12.5 mg (NDC 0071-0222-23) | Unavailable | 07 Aug 26 |
| Quinapril/Hydrochlorothiazide Tablet | Pfizer Inc. | Accuretic, Tablet, 20 mg/12.5 mg (NDC 0071-0220-23) | Unavailable | 07 Aug 26 |
| Remifentanil Hydrochloride Injection | Mylan Institutional, a Viatris Company | Ultiva, Injection, 5 mg (NDC 72078-036-05) | Available | 07 Aug 26 |
| Remifentanil Hydrochloride Injection | Mylan Institutional, a Viatris Company | Ultiva, Injection, 2 mg (NDC 72078-035-02) | Available | 07 Aug 26 |
| Remifentanil Hydrochloride Injection | Mylan Institutional, a Viatris Company | Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01) | Available | 07 Aug 26 |
| Remifentanil Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10) | Available | 07 Aug 26 |
| Remifentanil Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10) | Available | 07 Aug 26 |
| Remifentanil Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10) | Available | 07 Aug 26 |
| Rifampin Injection | Mylan Institutional, a Viatris Company | Rifampin, Injection, 600 mg (NDC 67457-445-60) | Unavailable | 07 Aug 26 |
| Rocuronium Bromide Injection | Hospira, Inc., a Pfizer Company | Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) | Available | 07 Aug 26 |
| Rocuronium Bromide Injection | Hospira, Inc., a Pfizer Company | Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) | Available | 07 Aug 26 |
| Rocuronium Bromide Injection | Mylan Institutional, a Viatris Company | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) | Available | 07 Aug 26 |
| Rocuronium Bromide Injection | Hospira, Inc., a Pfizer Company | Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) | Available | 07 Aug 26 |
| Rocuronium Bromide Injection | Mylan Institutional, a Viatris Company | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) | Available | 07 Aug 26 |
| Rocuronium Bromide Injection | Hospira, Inc., a Pfizer Company | Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) | Available | 07 Aug 26 |
| Sodium Acetate Injection | Hikma Pharmaceuticals USA, Inc. | Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01) | Unavailable | 07 Aug 26 |
| Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06) | Limited Availability | 07 Aug 26 |
| Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73) | Available | 07 Aug 26 |
| Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26) | Available | 07 Aug 26 |
| Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25) | Available | 07 Aug 26 |
| Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25) | Available | 07 Aug 26 |
| Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05) | Available | 07 Aug 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 5 mEq/10 mL (4.2%, 0.5 mEq/mL) Syringes (NDC 0409-5534-14) | Unavailable | 07 Aug 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01) | Unavailable | 07 Aug 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 10 mEq/10 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-4900-14) | Unavailable | 07 Aug 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14) | Available | 07 Aug 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35) | Unavailable | 07 Aug 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 44.6 mEq/50 mL (7.5%, 0.9 mEq/mL) Syringes (NDC 0409-4916-14) | Unavailable | 07 Aug 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-6637-14) | Unavailable | 07 Aug 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02) | Limited Availability | 07 Aug 26 |
| Sterile Water Injection | Hospira, Inc., a Pfizer Company | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-20) | Available | 07 Aug 26 |
| Sterile Water Injection | Hospira, Inc., a Pfizer Company | Bacteriostatic Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 0409-3977-03) | Limited Availability | 07 Aug 26 |
| Sterile Water Injection | Hospira, Inc., a Pfizer Company | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-10) | Available | 07 Aug 26 |
| Sterile Water Injection | Hospira, Inc., a Pfizer Company | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-50) | Available | 07 Aug 26 |
| Sterile Water Injection | Hospira, Inc., a Pfizer Company | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-99) | Available | 07 Aug 26 |
| Sterile Water Irrigant | B. Braun Medical Inc. | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-00) | Available | 07 Aug 26 |
| Sterile Water Irrigant | B. Braun Medical Inc. | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-10) | Available | 07 Aug 26 |
| Sufentanil Citrate Injection | Hospira, Inc., a Pfizer Company | Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21) | Unavailable | 07 Aug 26 |
| Azacitidine Injection | Eugia US LLC | Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01) | Unavailable | 06 Aug 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-172-30) | Available | 06 Aug 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-171-10) | Available | 06 Aug 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10) | Available | 06 Aug 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50) | Available | 06 Aug 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-169-10) | Available | 06 Aug 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50) | Available | 06 Aug 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-170-30) | Available | 06 Aug 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30) | Available | 06 Aug 26 |
| Carboplatin Injection | Eugia US LLC | Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01) | Available | 06 Aug 26 |
| Carboplatin Injection | Eugia US LLC | Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01) | Unavailable | 06 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Eugia US LLC | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25) | Available | 06 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Eugia US LLC | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02) | Available | 06 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Eugia US LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10) | Available | 06 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Eugia US LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10) | Available | 06 Aug 26 |
| Etomidate Injection | Eugia US LLC | Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10) | Unavailable | 06 Aug 26 |
| Etomidate Injection | Eugia US LLC | Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20) | Unavailable | 06 Aug 26 |
| Furosemide Injection | Eugia US LLC | Furosemide, Injection, 100 mg/10 mL (NDC 55150-324-25) | Available | 06 Aug 26 |
| Furosemide Injection | Eugia US LLC | Furosemide, Injection, 40 mg/4 mL (NDC 55150-323-25) | Available | 06 Aug 26 |
| Furosemide Injection | Eugia US LLC | Furosemide, Injection, 20 mg/2 mL (NDC 55150-322-25) | Unavailable | 06 Aug 26 |
| Isocarboxazid Tablet | Lifsa Drugs LLC | Marplan, Tablet, 10 mg, 100 count bottle (NDC 72336-032-01) | Limited Availability | 06 Aug 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02) | Available | 06 Aug 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02) | Available | 06 Aug 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74) | Unavailable | 06 Aug 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10) | Unavailable | 06 Aug 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50) | Unavailable | 06 Aug 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05) | Available | 06 Aug 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10) | Unavailable | 06 Aug 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20) | Unavailable | 06 Aug 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05) | Available | 06 Aug 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30) | Available | 06 Aug 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20) | Available | 06 Aug 26 |
| Methylprednisolone Acetate Injection | Eugia US LLC | Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01) | Unavailable | 06 Aug 26 |
| Methylprednisolone Acetate Injection | Eugia US LLC | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01) | Unavailable | 06 Aug 26 |
| Rocuronium Bromide Injection | Eugia US LLC | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10) | Available | 06 Aug 26 |
| Rocuronium Bromide Injection | Eugia US LLC | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05) | Available | 06 Aug 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99) | Available | 06 Aug 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20) | Unavailable | 06 Aug 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30) | Available | 06 Aug 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20) | Unavailable | 06 Aug 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20) | Available | 06 Aug 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20) | Available | 06 Aug 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10) | Unavailable | 06 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | SpecGx LLC | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0406-8892-01) | Limited Availability | 05 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | SpecGx LLC | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0406-8884-01) | Available | 05 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | SpecGx LLC | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0406-8893-01) | Available | 05 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | SpecGx LLC | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01) | Limited Availability | 05 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | SpecGx LLC | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0406-8891-01) | Limited Availability | 05 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | SpecGx LLC | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0406-8885-01) | Available | 05 Aug 26 |
| Atropine Sulfate Injection | Accord Healthcare Inc. | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43) | Unavailable | 05 Aug 26 |
| Atropine Sulfate Injection | Accord Healthcare Inc. | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08) | Unavailable | 05 Aug 26 |
| Azacitidine Injection | Dr. Reddy's Laboratories, Inc. | Azacitidine, Injection, 100 mg (NDC 43598-305-62) | Available | 05 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Par Health, USA LLC | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25) | Available | 05 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Par Health, USA LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10) | Unavailable | 05 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Par Health, USA LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20) | Unavailable | 05 Aug 26 |
| Furosemide Injection | Avet Pharmaceuticals, Inc. | Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44) | Unavailable | 05 Aug 26 |
| Furosemide Injection | Avet Pharmaceuticals, Inc. | Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-41) | Available | 05 Aug 26 |
| Furosemide Injection | Avet Pharmaceuticals, Inc. | Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-42) | Unavailable | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-048-88) | Limited Availability | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01) | Available | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01) | Available | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88) | Limited Availability | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88) | Limited Availability | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01) | Available | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88) | Limited Availability | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01) | Available | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88) | Limited Availability | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-048-88) | Limited Availability | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01) | Available | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88) | Limited Availability | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01) | Available | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01) | Available | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88) | Available | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88) | Available | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88) | Available | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88) | Available | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88) | Available | 05 Aug 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88) | Available | 05 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Sun Pharmaceutical Industries, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88) | Unavailable | 05 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Sun Pharmaceutical Industries, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88) | Unavailable | 05 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Sun Pharmaceutical Industries, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88) | Unavailable | 05 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Sun Pharmaceutical Industries, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88) | Unavailable | 05 Aug 26 |
| Methylprednisolone Acetate Injection | Par Health, USA LLC | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01) | Unavailable | 05 Aug 26 |
| Midazolam Hydrochloride Injection | Avet Pharmaceuticals, Inc. | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41) | Limited Availability | 05 Aug 26 |
| Midazolam Hydrochloride Injection | Avet Pharmaceuticals, Inc. | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41) | Available | 05 Aug 26 |
| Midazolam Hydrochloride Injection | Avet Pharmaceuticals, Inc. | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42) | Available | 05 Aug 26 |
| Technetium TC-99M Pyrophosphate Kit Injection | Sun Pharmaceutical Industries, Inc. | CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-2) | Unavailable | 05 Aug 26 |
| Technetium TC-99M Pyrophosphate Kit Injection | Sun Pharmaceutical Industries, Inc. | CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1) | Unavailable | 05 Aug 26 |
| Albuterol Sulfate Solution | Nephron Pharmaceuticals Corporation | Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30) | Available | 04 Aug 26 |
| Albuterol Sulfate Solution | Ritedose Pharmaceuticals, LLC | Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01) | Available | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Oryza Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 72516-012-01) | Unavailable | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0527-1502-37) | Limited Availability | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Oryza Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 72516-016-01) | Unavailable | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Oryza Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01) | Unavailable | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0555-0971-02) | Limited Availability | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0527-1505-37) | Available | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0527-0760-37) | Available | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0527-0764-37) | Available | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0527-0761-37) | Available | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Oryza Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01) | Unavailable | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Oryza Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 72516-013-01) | Unavailable | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0555-0974-02) | Limited Availability | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0527-0763-37) | Available | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01) | Unavailable | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0555-0973-02) | Limited Availability | 04 Aug 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0527-0766-37) | Available | 04 Aug 26 |
| Atropine Sulfate Injection | Fresenius Kabi USA, LLC | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20) | Available | 04 Aug 26 |
| Azacitidine Injection | Fresenius Kabi USA, LLC | Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39) | Unavailable | 04 Aug 26 |
| Bumetanide Injection | Sagent Pharmaceuticals | Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-10) | Available | 04 Aug 26 |
| Bumetanide Injection | Fresenius Kabi USA, LLC | Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10) | Available | 04 Aug 26 |
| Bumetanide Injection | Fresenius Kabi USA, LLC | Bumetanide, Injection, .25 mg/1 mL (NDC 65219-570-04) | Available | 04 Aug 26 |
| Bumetanide Injection | Sagent Pharmaceuticals | Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-04) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31) | Unavailable | 04 Aug 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31) | Unavailable | 04 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 7.5 mg/1 mL; .005 mg/1 mL (NDC 63323-460-37) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-37) | Unavailable | 04 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-17) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31) | Unavailable | 04 Aug 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17) | Available | 04 Aug 26 |
| Carboplatin Injection | Avyxa Pharma, LLC | Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08) | Available | 04 Aug 26 |
| Carboplatin Injection | Fresenius Kabi USA, LLC | Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60) | Unavailable | 04 Aug 26 |
| Carboplatin Injection | Teva Pharmaceuticals USA, Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01) | Limited Availability | 04 Aug 26 |
| Carboplatin Injection | Teva Pharmaceuticals USA, Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01) | Limited Availability | 04 Aug 26 |
| Carboplatin Injection | Teva Pharmaceuticals USA, Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01) | Limited Availability | 04 Aug 26 |
| Carboplatin Injection | Teva Pharmaceuticals USA, Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01) | Unavailable | 04 Aug 26 |
| Carboplatin Injection | Avyxa Pharma, LLC | Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50) | Available | 04 Aug 26 |
| Clindamycin Phosphate Injection | Sagent Pharmaceuticals | Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04) | Unavailable | 04 Aug 26 |
| Clindamycin Phosphate Injection | Sagent Pharmaceuticals | Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02) | Limited Availability | 04 Aug 26 |
| Clindamycin Phosphate Injection | Sagent Pharmaceuticals | Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06) | Limited Availability | 04 Aug 26 |
| Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Clonazepam, Tablet, 1 mg (NDC 0093-3212-01) | Limited Availability | 04 Aug 26 |
| Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Clonazepam, Tablet, .5 mg (NDC 0093-0832-05) | Limited Availability | 04 Aug 26 |
| Desmopressin Acetate Spray | Apotex Corp. | Desmopressin Acetate (needs No Refrigeration), Spray, 10 ug (NDC 60505-0815-0) | Limited Availability | 04 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10) | Limited Availability | 04 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01) | Available | 04 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10) | Limited Availability | 04 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10) | Available | 04 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01) | Available | 04 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05) | Available | 04 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10) | Available | 04 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30) | Available | 04 Aug 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10) | Available | 04 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Fresenius Kabi USA, LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00) | Unavailable | 04 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Fresenius Kabi USA, LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50) | Unavailable | 04 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Fresenius Kabi USA, LLC | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02) | Unavailable | 04 Aug 26 |
| Dexmedetomidine Hydrochloride Injection | Fresenius Kabi USA, LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20) | Unavailable | 04 Aug 26 |
| Dextrose Monohydrate 10% Injection | Fresenius Kabi USA, LLC | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74) | Available | 04 Aug 26 |
| Dextrose Monohydrate 10% Injection | Fresenius Kabi USA, LLC | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75) | Available | 04 Aug 26 |
| Dextrose Monohydrate 10% Injection | Fresenius Kabi USA, LLC | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76) | Available | 04 Aug 26 |
| Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-464-50) | Available | 04 Aug 26 |
| Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-458-30) | Limited Availability | 04 Aug 26 |
| Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-456-60) | Available | 04 Aug 26 |
| Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-462-10) | Unavailable | 04 Aug 26 |
| Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-460-20) | Available | 04 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57) | Unavailable | 04 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57) | Available | 04 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17) | Available | 04 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17) | Available | 04 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27) | Unavailable | 04 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57) | Available | 04 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27) | Available | 04 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37) | Available | 04 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37) | Available | 04 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17) | Available | 04 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27) | Available | 04 Aug 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17) | Available | 04 Aug 26 |
| Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05) | Available | 04 Aug 26 |
| Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50) | Unavailable | 04 Aug 26 |
| Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01) | Available | 04 Aug 26 |
| Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11) | Available | 04 Aug 26 |
| Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20) | Available | 04 Aug 26 |
| Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02) | Available | 04 Aug 26 |
| Flurazepam Hydrochloride Capsule | Chartwell Molecular Holdings LLC | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90) | Available | 04 Aug 26 |
| Flurazepam Hydrochloride Capsule | Chartwell Molecular Holdings LLC | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30) | Available | 04 Aug 26 |
| Flurazepam Hydrochloride Capsule | Chartwell Molecular Holdings LLC | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30) | Available | 04 Aug 26 |
| Flurazepam Hydrochloride Capsule | Chartwell Molecular Holdings LLC | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90) | Available | 04 Aug 26 |
| Furosemide Injection | Fresenius Kabi USA, LLC | Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-02) | Available | 04 Aug 26 |
| Furosemide Injection | Fresenius Kabi USA, LLC | Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04) | Available | 04 Aug 26 |
| Furosemide Injection | Fresenius Kabi USA, LLC | Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-10) | Available | 04 Aug 26 |
| Heparin Sodium Injection | Fresenius Kabi USA, LLC | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10) | Available | 04 Aug 26 |
| Heparin Sodium Injection | Fresenius Kabi USA, LLC | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77) | Available | 04 Aug 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50) | Available | 04 Aug 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) | Unavailable | 04 Aug 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25) | Available | 04 Aug 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) | Available | 04 Aug 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10) | Available | 04 Aug 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15) | Unavailable | 04 Aug 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25) | Available | 04 Aug 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11) | Unavailable | 04 Aug 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10) | Available | 04 Aug 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06) | Unavailable | 04 Aug 26 |
| Hydroxocobalamin Injection | Teva Pharmaceuticals USA, Inc. | Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30) | Unavailable | 04 Aug 26 |
| Ifosfamide Injection | Fresenius Kabi USA, LLC | Ifosfamide, Injection, 1 g (NDC 63323-142-10) | Unavailable | 04 Aug 26 |
| Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) | Unavailable | 04 Aug 26 |
| Ketorolac Tromethamine Injection | Sagent Pharmaceuticals | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Available | 04 Aug 26 |
| Ketorolac Tromethamine Injection | Sagent Pharmaceuticals | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Available | 04 Aug 26 |
| Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) | Unavailable | 04 Aug 26 |
| Ketorolac Tromethamine Injection | Sagent Pharmaceuticals | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Available | 04 Aug 26 |
| Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) | Unavailable | 04 Aug 26 |
| Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) | Unavailable | 04 Aug 26 |
| Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) | Unavailable | 04 Aug 26 |
| Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Anthea Pharma | Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91) | Unavailable | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Anthea Pharma | Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02) | Unavailable | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Anthea Pharma | Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27) | Unavailable | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57) | Unavailable | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97) | Unavailable | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Anthea Pharma | Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31) | Unavailable | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97) | Unavailable | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Anthea Pharma | Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02) | Unavailable | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Anthea Pharma | Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20) | Available | 04 Aug 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57) | Available | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1) | Limited Availability | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37) | Available | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37) | Available | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37) | Available | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1) | Unavailable | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37) | Available | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37) | Available | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37) | Available | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1) | Available | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1) | Available | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1) | Available | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1) | Available | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1) | Unavailable | 04 Aug 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37) | Available | 04 Aug 26 |
| Lorazepam Injection | Fresenius Kabi USA, LLC | Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02) | Available | 04 Aug 26 |
| Methotrexate Sodium Injection | Teva Pharmaceuticals USA, Inc. | Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3675-01) | Limited Availability | 04 Aug 26 |
| Methotrexate Sodium Injection | Teva Pharmaceuticals USA, Inc. | Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01) | Limited Availability | 04 Aug 26 |
| Methotrexate Sodium Injection | Fresenius Kabi USA, LLC | Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10) | Available | 04 Aug 26 |
| Methotrexate Sodium Injection | Fresenius Kabi USA, LLC | Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50) | Available | 04 Aug 26 |
| Methotrexate Sodium Injection | Teva Pharmaceuticals USA, Inc. | Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01) | Limited Availability | 04 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Teva Pharmaceuticals USA, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01) | Limited Availability | 04 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Teva Pharmaceuticals USA, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01) | Available | 04 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Janssen Pharmaceuticals | Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01) | Available | 04 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Janssen Pharmaceuticals | Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01) | Available | 04 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Teva Pharmaceuticals USA, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01) | Available | 04 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Lannett Company, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37) | Available | 04 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Lannett Company, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37) | Available | 04 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Lannett Company, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37) | Available | 04 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Janssen Pharmaceuticals | Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01) | Available | 04 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Janssen Pharmaceuticals | Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01) | Available | 04 Aug 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Lannett Company, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37) | Available | 04 Aug 26 |
| Methylprednisolone Acetate Injection | Sagent Pharmaceuticals | Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05) | Unavailable | 04 Aug 26 |
| Methylprednisolone Acetate Injection | Sagent Pharmaceuticals | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05) | Limited Availability | 04 Aug 26 |
| Methylprednisolone Acetate Injection | Sagent Pharmaceuticals | Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10) | Unavailable | 04 Aug 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20) | Unavailable | 04 Aug 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02) | Available | 04 Aug 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25) | Available | 04 Aug 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10) | Unavailable | 04 Aug 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25) | Unavailable | 04 Aug 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12) | Unavailable | 04 Aug 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10) | Unavailable | 04 Aug 26 |
| Morphine Sulfate Injection | Piramal Critical Care Inc. | Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02) | Limited Availability | 04 Aug 26 |
| Morphine Sulfate Injection | Fresenius Kabi USA, LLC | Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01) | Unavailable | 04 Aug 26 |
| Morphine Sulfate Injection | Fresenius Kabi USA, LLC | Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01) | Available | 04 Aug 26 |
| Morphine Sulfate Injection | Fresenius Kabi USA, LLC | Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11) | Unavailable | 04 Aug 26 |
| Morphine Sulfate Injection | Fresenius Kabi USA, LLC | Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01) | Available | 04 Aug 26 |
| Morphine Sulfate Injection | Fresenius Kabi USA, LLC | Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11) | Unavailable | 04 Aug 26 |
| Morphine Sulfate Injection | Piramal Critical Care Inc. | Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02) | Available | 04 Aug 26 |
| Morphine Sulfate Injection | Fresenius Kabi USA, LLC | Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01) | Available | 04 Aug 26 |
| Propranolol Hydrochloride Injection | Fresenius Kabi USA, LLC | Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01) | Available | 04 Aug 26 |
| Quinapril Hydrochloride Tablet | Chartwell Molecular Holdings LLC | Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90) | Available | 04 Aug 26 |
| Quinapril Hydrochloride Tablet | Chartwell Molecular Holdings LLC | Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90) | Available | 04 Aug 26 |
| Quinapril Hydrochloride Tablet | Chartwell Molecular Holdings LLC | Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90) | Available | 04 Aug 26 |
| Quinapril Hydrochloride Tablet | Chartwell Molecular Holdings LLC | Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60) | Available | 04 Aug 26 |
| Quinapril/Hydrochlorothiazide Tablet | Chartwell Molecular Holdings LLC | Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90) | Available | 04 Aug 26 |
| Quinapril/Hydrochlorothiazide Tablet | Chartwell Molecular Holdings LLC | Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90) | Available | 04 Aug 26 |
| Quinapril/Hydrochlorothiazide Tablet | Chartwell Molecular Holdings LLC | Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90) | Available | 04 Aug 26 |
| Remifentanil Hydrochloride Injection | Fresenius Kabi USA, LLC | Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03) | Available | 04 Aug 26 |
| Remifentanil Hydrochloride Injection | Fresenius Kabi USA, LLC | Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10) | Available | 04 Aug 26 |
| Remifentanil Hydrochloride Injection | Fresenius Kabi USA, LLC | Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05) | Unavailable | 04 Aug 26 |
| Rifampin Capsule | Lupin Pharmaceuticals, Inc. | Rifampin, Capsule, 300 mg (NDC 68180-659-06) | Limited Availability | 04 Aug 26 |
| Rifampin Capsule | Lupin Pharmaceuticals, Inc. | Rifampin, Capsule, 150 mg (NDC 68180-658-06) | Limited Availability | 04 Aug 26 |
| Rifampin Capsule | Lupin Pharmaceuticals, Inc. | Rifampin, Capsule, 300 mg (NDC 68180-659-07) | Limited Availability | 04 Aug 26 |
| Rifampin Injection | Fresenius Kabi USA, LLC | Rifampin, Injection, 600 mg (NDC 63323-351-20) | Unavailable | 04 Aug 26 |
| Rocuronium Bromide Injection | Sagent Pharmaceuticals | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) | Available | 04 Aug 26 |
| Rocuronium Bromide Injection | Piramal Critical Care Inc. | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41) | Limited Availability | 04 Aug 26 |
| Rocuronium Bromide Injection | Piramal Critical Care Inc. | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41) | Limited Availability | 04 Aug 26 |
| Rocuronium Bromide Injection | Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) | Available | 04 Aug 26 |
| Rocuronium Bromide Injection | Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) | Unavailable | 04 Aug 26 |
| Rocuronium Bromide Injection | Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10) | Available | 04 Aug 26 |
| Rocuronium Bromide Injection | Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05) | Available | 04 Aug 26 |
| Rocuronium Bromide Injection | Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) | Unavailable | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) | Unavailable | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) | Unavailable | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) | Unavailable | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) | Unavailable | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) | Unavailable | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) | Unavailable | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) | Unavailable | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) | Unavailable | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) | Available | 04 Aug 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) | Available | 04 Aug 26 |
| Sodium Acetate Injection | Fresenius Kabi USA, LLC | Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00) | Available | 04 Aug 26 |
| Sodium Bicarbonate Injection | Fresenius Kabi USA, LLC | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50) | Available | 04 Aug 26 |
| Sodium Bicarbonate Injection | Fresenius Kabi USA, LLC | Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05) | Available | 04 Aug 26 |
| Sterile Water Injection | Fresenius Kabi USA, LLC | Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-50) | Available | 04 Aug 26 |
| Sterile Water Injection | Nephron Pharmaceuticals Corporation | Sterile Water, Injection, 1 mL/1 mL (NDC 0487-6105-01) | Limited Availability | 04 Aug 26 |
| Sterile Water Injection | Fresenius Kabi USA, LLC | Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-10) | Unavailable | 04 Aug 26 |
| Sterile Water Injection | Fresenius Kabi USA, LLC | Sterile Water, Injection, 1000 mL/1000 mL (NDC 63323-178-76) | Available | 04 Aug 26 |
| Sterile Water Injection | Fresenius Kabi USA, LLC | Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-20) | Available | 04 Aug 26 |
| Streptozocin Powder, For Solution | Teva Pharmaceuticals USA, Inc. | Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01) | Unavailable | 04 Aug 26 |
| Valproate Sodium Injection | Fresenius Kabi USA, LLC | Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05) | Available | 04 Aug 26 |
| Bupivacaine Hydrochloride Injection | Huons Co., Ltd | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2) | Unavailable | 30 Jul 26 |
| Dexmedetomidine Hydrochloride Injection | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02) | Available | 30 Jul 26 |
| Dexmedetomidine Hydrochloride Injection | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95) | Available | 30 Jul 26 |
| Dexmedetomidine Hydrochloride Injection | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95) | Available | 30 Jul 26 |
| Dexmedetomidine Hydrochloride Injection | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95) | Available | 30 Jul 26 |
| Lidocaine Hydrochloride Injection | Huons Co., Ltd. (South Korea) | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2) | Unavailable | 30 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 70010-117-01) | Unavailable | 24 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01) | Unavailable | 24 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 70010-112-01) | Unavailable | 24 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 70010-115-01) | Unavailable | 24 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 70010-114-01) | Unavailable | 24 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 70010-116-01) | Unavailable | 24 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 70010-113-01) | Unavailable | 24 Jul 26 |
| Carboplatin Injection | Gland Pharma Limited | Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01) | Unavailable | 22 Jul 26 |
| Carboplatin Injection | Gland Pharma Limited | Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01) | Limited Availability | 22 Jul 26 |
| Carboplatin Injection | Gland Pharma Limited | Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01) | Limited Availability | 22 Jul 26 |
| Carboplatin Injection | Gland Pharma Limited | Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01) | Limited Availability | 22 Jul 26 |
| Dexmedetomidine Hydrochloride Injection | Gland Pharma Limited | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58) | Available | 22 Jul 26 |
| Dexmedetomidine Hydrochloride Injection | Gland Pharma Limited | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58) | Available | 22 Jul 26 |
| Dexmedetomidine Hydrochloride Injection | Gland Pharma Limited | Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42) | Available | 22 Jul 26 |
| Etomidate Injection | Gland Pharma Limited | Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10) | Available | 22 Jul 26 |
| Etomidate Injection | Gland Pharma Limited | Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10) | Available | 22 Jul 26 |
| Furosemide Injection | Gland Pharma Limited | Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04) | Unavailable | 22 Jul 26 |
| Furosemide Injection | Gland Pharma Limited | Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10) | Unavailable | 22 Jul 26 |
| Furosemide Injection | Gland Pharma Limited | Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02) | Unavailable | 22 Jul 26 |
| Ketorolac Tromethamine Injection | Gland Pharma Limited | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Available | 22 Jul 26 |
| Ketorolac Tromethamine Injection | Gland Pharma Limited | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) | Available | 22 Jul 26 |
| Ketorolac Tromethamine Injection | Gland Pharma Limited | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) | Available | 22 Jul 26 |
| Ketorolac Tromethamine Injection | Gland Pharma Limited | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Available | 22 Jul 26 |
| Ketorolac Tromethamine Injection | Gland Pharma Limited | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Available | 22 Jul 26 |
| Metronidazole Injection | Gland Pharma Limited | Metronidazole In Plastic Container, Injection, 500 mg/100 mL (NDC 47335-993-01) | Unavailable | 22 Jul 26 |
| Midazolam Hydrochloride Injection | Gland Pharma Limited | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10) | Unavailable | 22 Jul 26 |
| Midazolam Hydrochloride Injection | Gland Pharma Limited | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02) | Unavailable | 22 Jul 26 |
| Sodium Bicarbonate Injection | Exela Pharma Sciences, LLC | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4) | Available | 22 Jul 26 |
| Sodium Bicarbonate Injection | Exela Pharma Sciences, LLC | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5) | Available | 22 Jul 26 |
| Sodium Bicarbonate Injection | Exela Pharma Sciences, LLC | Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4) | Available | 22 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Aurobindo Pharma USA | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 13107-074-01) | Unavailable | 21 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Aurobindo Pharma USA | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 13107-069-01) | Unavailable | 21 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Aurobindo Pharma USA | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 13107-072-01) | Unavailable | 21 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Aurobindo Pharma USA | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 13107-073-01) | Unavailable | 21 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Aurobindo Pharma USA | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 13107-070-01) | Unavailable | 21 Jul 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Aurobindo Pharma USA | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 13107-068-01) | Unavailable | 21 Jul 26 |
| Conivaptan Hydrochloride Injection | Cumberland Pharmaceuticals Inc. | Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10) | Unavailable | 21 Jul 26 |
| Atropine Sulfate Injection | Somerset Therapeutics, LLC | Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25) | Available | 20 Jul 26 |
| Atropine Sulfate Injection | Somerset Therapeutics, LLC | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25) | Available | 20 Jul 26 |
| Atropine Sulfate Injection | Somerset Therapeutics, LLC | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10) | Available | 20 Jul 26 |
| Bupivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-01) | Available | 20 Jul 26 |
| Bupivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-25) | Available | 20 Jul 26 |
| Bupivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25) | Available | 20 Jul 26 |
| Bupivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-10) | Available | 20 Jul 26 |
| Bupivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01) | Available | 20 Jul 26 |
Showing the 1,000 most recently updated of 1,174 active shortages.
For manufacturers
A shortage is a sourcing event.
Every product on this list is a molecule somebody urgently needs another source for. If you hold registered capacity for any of them, list it and we will route matching requests to you.
Provenance
Source: FDA drug shortage database via openFDA, refreshed daily. Note that the openFDA feed carries no reason-for-shortage field, so availability and therapeutic category are shown instead of a cause. Shortage status changes between refreshes; check the FDA database directly before acting on it clinically. This site is not affiliated with the FDA.